Treatment Supported by Evidence from Multiple Studies and Renal Denervation Position Paper from the European Society of Hypertension PALO ALTO,...
ASHLAND, Ore.--(BUSINESS WIRE)--#cerner--As a major employer and key provider of health services in Inyo County, California, Northern Inyo Healthcare District...
The multi-site ophthalmology practice sought a partner that could modernize their business and help maintain their reputation for innovative patient...
HAMILTON, BERMUDA / ACCESSWIRE / October 6, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated...
RedHill Biopharma's Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization RequirementsAddition of Talicia® by Medi-Cal Fee-For-Service (FFS)...
Former Chief People Officer of OODA Health and Ginger Joins H1 Traunza Adams Joins H1 as Chief People Officer as...
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and...
Chiesi USA Durham Bulls Partnership Check Presentation Mike Wasyluk, Director of New Product Planning for Chiesi, presents the strikeout donations...
An interactive conversation regarding the importance of industry and investor commitment to women’s health innovationSAN DIEGO, Oct. 06, 2021 (GLOBE...
BOTHELL, Wash., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology...
VANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Resonant’s XBAR® Technology to be Leveraged Across Additional BandsAUSTIN, Texas, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN),...
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the...
FDA sets PDUFA target action date of June 5, 2022NEWTON, Mass. and GENEVA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acer...
First Phase 3 Study is Initiated to Evaluate Safety and Efficacy of Simufilam Over 52 Weeks in 750 Patients with...
Increases in lumbar spine, femoral neck and total hip BMD demonstrated with EB613 Linear Dose Responses Seen in Biomarker and...
Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectivelyLAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) --...
FLORHAM PARK, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Quanta, Inc. Figure 1.1 BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a...
Acquisition Delivers AI and Data Engineering Expertise, Enterprise Analytics and Technology-Enabled Solutions to Accelerate Customer PerformanceMORRISVILLE, N.C., Oct. 06, 2021...